Launching a Probiotic into Asia
Diverse pathways to entering Asia Pacific Markets.
15/04/20 10.30 (GMT+2)
                                                             
                                                                                                                                    S. Barbato                                                                
                                                Production of good silage has been the target of the work of an entire year. Driving the fermentation […]
15/04/20 17.00 (GMT+2)
                                                             
                                                                                                                                    S. Barbato                                                                
                                                Production of good silage has been the target of the work of an entire year. Driving the fermentation […]
07/05/20 10.30 (GMT+2)
                                                             
                                                                                                                                    S. Barbato                                                                
                                                Produrre un buon insilato è l’obiettivo di un’intera stagione. Guidarne la fermentazione lattica […]
13/05/20 10.30 (GMT+2)
                                                             
                                                                                                                                    C. SALA - S. LAVASANI (Founder & CEO ImmuneBiotech)                                                                
                                                Bacterial interventions focused to repair the disrupted gut microbiota have not been impressive […]
13/05/20 17.00 (GMT+2)
                                                             
                                                                                                                                    C. SALA - S. LAVASANI (Founder & CEO ImmuneBiotech)                                                                
                                                Bacterial interventions focused to repair the disrupted gut microbiota have not been impressive […]
